Stein Robert Benjamin 4
4 · MIMEDX GROUP, INC. · Filed May 17, 2023
Insider Transaction Report
Form 4
Stein Robert Benjamin
EVP, Research and Development
Transactions
- Sale
Common Stock
2023-05-16$5.95/sh−10,365$61,627→ 317,803 total - Sale
Common Stock
2023-05-15$6.15/sh−3,607$22,170→ 328,168 total
Footnotes (2)
- [F1]The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $6.120 to $6.190, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.
- [F2]The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $5.870 to $6.025, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.